Genetic Polymorphisms in Enzymes Involved in One-Carbon Metabolism and Anti-epileptic Drug Monotherapy on Homocysteine Metabolism in Patients With Epilepsy

Overview

Journal Front Neurol

Specialty Neurology

Date 2021 Jun 28

PMID 34177787

Citations 6

Authors

Shaofang Zhu

Guanzhong Ni

Lisen Sui

Yiran Zhao

Xiaoxu Zhang

Qilin Dai

Aohan Chen

Wanrong Lin

Yinchao Li

Min Huang

Liemin Zhou

Affiliations

Soon will be listed here.

Abstract

To investigate the effects of single nucleotide polymorphisms (SNPs) in genes of one-carbon metabolism (OCM) related enzymes and anti-epileptic drug (AED) monotherapy on homocysteine (Hcy) metabolism in patients with epilepsy, and to further explore specific SNPs that may increase patients' susceptibility to the effects of AEDs on the Hcy imbalance. This case-control study analyzed 279 patients with epilepsy, including patients receiving monotherapy with valproate (VPA) ( = 53), oxcarbazepine (OXC) ( = 71), lamotrigine (LTG) ( = 55), or levetiracetam (LEV) ( = 35) and patients who had not taken any AEDs (controls, = 65) for at least 6 months. Serum levels of vitamin B12 (vit B12), folate (FA) and Hcy were measured, and 23 SNPs in 13 genes of OCM-related enzymes were genotyped in all patients. Methylenetetrahydrofolate reductase () rs1801133 was associated with elevated serum Hcy levels in patients with epilepsy ( < 0.001), and patients presenting the TT genotype exhibited higher serum Hcy levels than patients with the CC ( < 0.001) or CT ( < 0.001) genotype. A subsequent multiple linear regression analysis showed that AED monotherapy with VPA (vs. control: = 0.023) or OXC (vs. control: = 0.041), and genotypes of rs1801133 TT (vs. CC: < 0.001; vs. CT: < 0.001), transcobalamin 2 () rs1801198 CC (vs. GC: = 0.039) and folate receptor 1 () rs2071010 AA (vs. GA: = 0.031) were independent risk factors for higher Hcy levels. In the subgroup analysis of patients taking OXC, we found that patients with genotypes of rs1801133 TT (vs. CC: = 0.001; vs. CT: < 0.001) and rs1801198 CC (vs. GC: = 0.021; vs. GG: = 0.018) exhibited higher serum Hcy levels. VPA, OXC, and genotypes of rs1801133 TT, rs1801198 CC, and rs2071010 AA are all independent risk factors for elevated Hcy levels in patients with epilepsy. Moreover, genotypes of rs1801133 TT and rs1801198 CC may increase patients' susceptibility to the effect of OXC on disrupting Hcy homeostasis.

Citing Articles

Associations between one-carbon metabolism and valproic acid-induced liver dysfunction in epileptic patients.

Zhu J, Wang Z, Sun X, Wang D, Xu X, Yang L Front Pharmacol. 2024; 15:1358262.

PMID: 38464726 PMC: 10924308. DOI: 10.3389/fphar.2024.1358262.

PERCHING syndrome caused by variant gene KLHL7 in the first Iranian patient: a case report study.

Ghelichi-Ghojogh M, Golfiroozi S, Delavari S, Hosseini S Ann Med Surg (Lond). 2024; 86(2):1048-1051.

PMID: 38333279 PMC: 10849426. DOI: 10.1097/MS9.0000000000001429.

Valproic Acid in Pregnancy Revisited: Neurobehavioral, Biochemical and Molecular Changes Affecting the Embryo and Fetus in Humans and in Animals: A Narrative Review.

Ornoy A, Echefu B, Becker M Int J Mol Sci. 2024; 25(1).

PMID: 38203562 PMC: 10779436. DOI: 10.3390/ijms25010390.

Susceptibility to preoperative seizures in glioma patients with elevated homocysteine levels.

Chi X, Lu J, Guo Z, Wang J, Liu G, Jin Z Epilepsia Open. 2023; 8(4):1350-1361.

PMID: 37491869 PMC: 10690701. DOI: 10.1002/epi4.12797.

Is There a Relation between 677C>T Polymorphism in the Gene and the Susceptibility to Epilepsy in Young Patients? A Meta-Analysis.

Sarecka-Hujar B Brain Sci. 2021; 11(10).

PMID: 34679392 PMC: 8533948. DOI: 10.3390/brainsci11101327.

References

Ni G, Qin J, Chen Z, Li H, Zhou J, Huang M . Associations between genetic variation in one-carbon metabolism and leukocyte DNA methylation in valproate-treated patients with epilepsy. Clin Nutr. 2017; 37(1):308-312. DOI: 10.1016/j.clnu.2017.01.004. View

Liu J, Qi J, Yu X, Zhu J, Zhang L, Ning Q . Investigations of single nucleotide polymorphisms in folate pathway genes in Chinese families with neural tube defects. J Neurol Sci. 2013; 337(1-2):61-6. DOI: 10.1016/j.jns.2013.11.017. View

Seshadri S, Beiser A, Selhub J, Jacques P, Rosenberg I, DAgostino R . Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002; 346(7):476-83. DOI: 10.1056/NEJMoa011613. View

Kim D, Lee S, Shon Y, Kim J . Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy. Epilepsia. 2013; 54(10):e146-9. DOI: 10.1111/epi.12338. View

Ni G, Qin J, Li H, Chen Z, Zhou Y, Fang Z . Effects of antiepileptic drug monotherapy on one-carbon metabolism and DNA methylation in patients with epilepsy. PLoS One. 2015; 10(4):e0125656. PMC: 4410915. DOI: 10.1371/journal.pone.0125656. View

Soinio M, Marniemi J, Laakso M, Lehto S, Ronnemaa T . Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus. Ann Intern Med. 2004; 140(2):94-100. DOI: 10.7326/0003-4819-140-2-200401200-00009. View

Perucca P, Scheffer I, Kiley M . The management of epilepsy in children and adults. Med J Aust. 2018; 208(5):226-233. DOI: 10.5694/mja17.00951. View

Tanne D, Haim M, Goldbourt U, Boyko V, Doolman R, Adler Y . Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease. Stroke. 2003; 34(3):632-6. DOI: 10.1161/01.STR.0000060203.58958.35. View

Bochynska A, Lipczynska-Lojkowska W, Gugala-Iwaniuk M, Lechowicz W, Restel M, Graban A . The effect of vitamin B supplementation on homocysteine metabolism and clinical state of patients with chronic epilepsy treated with carbamazepine and valproic acid. Seizure. 2012; 21(4):276-81. DOI: 10.1016/j.seizure.2012.01.013. View

10.

Carinci F, Palmieri A, Scapoli L, Cura F, Abenavoli F, Gianni A . Association between oral cleft and transcobalamin 2 polymorphism in a sample study from Nassiriya, Iraq. Int J Immunopathol Pharmacol. 2019; 33:2058738419855571. PMC: 6822189. DOI: 10.1177/2058738419855571. View

11.

Belcastro V, Striano P, Gorgone G, Costa C, Ciampa C, Caccamo D . Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs. Epilepsia. 2009; 51(2):274-9. DOI: 10.1111/j.1528-1167.2009.02303.x. View

12.

Amorim M, Moura C, Gomes A, Barboza H, Lopes R, Ribeiro M . Betaine-homocysteine methyltransferase 742G>A polymorphism and risk of down syndrome offspring in a Brazilian population. Mol Biol Rep. 2013; 40(8):4685-9. DOI: 10.1007/s11033-013-2563-x. View

13.

Tanaka T, Scheet P, Giusti B, Bandinelli S, Piras M, Usala G . Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations. Am J Hum Genet. 2009; 84(4):477-82. PMC: 2667971. DOI: 10.1016/j.ajhg.2009.02.011. View

14.

Li Z, Sun L, Zhang H, Liao Y, Wang D, Zhao B . Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter Case-Control Study in China. Stroke. 2003; 34(9):2085-90. DOI: 10.1161/01.STR.0000086753.00555.0D. View

15.

Emeksiz H, Serdaroglu A, Biberoglu G, Gulbahar O, Arhan E, Cansu A . Assessment of atherosclerosis risk due to the homocysteine-asymmetric dimethylarginine-nitric oxide cascade in children taking antiepileptic drugs. Seizure. 2012; 22(2):124-7. DOI: 10.1016/j.seizure.2012.11.007. View

16.

Chango A, Boisson F, Barbe F, Quilliot D, Droesch S, Pfister M . The effect of 677C-->T and 1298A-->C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects. Br J Nutr. 2000; 83(6):593-6. DOI: 10.1017/s0007114500000751. View

17.

Kurosawa Y, Furugen A, Nishimura A, Narumi K, Kobayashi M, Iseki K . Evaluation of the effects of antiepileptic drugs on folic acid uptake by human placental choriocarcinoma cells. Toxicol In Vitro. 2017; 48:104-110. DOI: 10.1016/j.tiv.2017.12.003. View

18.

Dhonukshe-Rutten R, Pluijm S, de Groot L, Lips P, Smit J, van Staveren W . Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J Bone Miner Res. 2005; 20(6):921-9. DOI: 10.1359/JBMR.050202. View

19.

Schalinske K, Smazal A . Homocysteine imbalance: a pathological metabolic marker. Adv Nutr. 2012; 3(6):755-62. PMC: 3648699. DOI: 10.3945/an.112.002758. View

20.

Rezaei S, Shab-Bidar S, Abdurahman A, Djafarian K . Oxcarbazepine administration and the serum levels of homocysteine, vitamin B12 and folate in epileptic patients: A systematic review and meta-analysis. Seizure. 2016; 45:87-94. DOI: 10.1016/j.seizure.2016.11.016. View